Abstract TH244: Rising Hypertensive Heart Disease Mortality Among U.S. Adolescents and Young Adults Aged 15-29 Years, 1999-2020
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Khushbu Patel und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hypertensive heart disease (HHD) is an uncommon but preventable cause of premature cardiovascular mortality among adolescents and young adults. We evaluated contemporary U.S. mortality patterns from hypertensive diseases, with emphasis on HHD, among persons aged 15-29 years from 1999-2020.
Methods
CDC WONDER Multiple Cause of Death data were analyzed for deaths with underlying-cause as HHD among persons aged 15-29 years. Deaths, population, and crude mortality rates per 100,000 were assessed overall and by hypertensive subtype, sex, 5-year age group, race, Hispanic origin, census region, urbanization, place of death, and state. Annualized percentage change (APC) was estimated using Poisson log-linear regression with population offset; Bayesian information criterion-selected segmented models assessed temporal inflection.
Results
From 1999-2020, 5,006 hypertensive-disease deaths occurred among persons aged 15-29 years. Annual deaths increased from 131 in 1999 to 298 in 2020 (+127.5%), while the mortality rate rose from 0.22 to 0.45 per 100,000 (+101.4%). Overall mortality increased 2.0% per year (95% CI, 1.5-2.6), with sustained growth in 1999-2014 (APC +2.0%) and 2015-2020 (APC +2.0%) and no modeled period of decline. HHD accounted for most deaths: I11.0/I11.9 comprised 3,480 deaths (69.5%) overall and 228 deaths (76.5%) in 2020; HHD mortality increased 3.2% per year. Males accounted for 3,493 deaths (69.8%) and had a higher 2020 rate than females (0.62 vs 0.27 per 100,000). Mortality was concentrated at ages 25-29 years, which accounted for 3,424 deaths (68.4%) and had the highest 2020 rate (0.95 per 100,000), compared with 0.29 at ages 20-24 and 0.07 at ages 15-19 years. In 2020, Black individuals had 143 deaths and the highest racial mortality rate (1.32 per 100,000), compared with 142 deaths and 0.29 per 100,000 among White individuals. The South accounted for 2,510 deaths (50.1%) and had the highest 2020 regional rate (0.68 per 100,000). Deaths at home represented 127 of 289 place-classified deaths in 2020 (43.9%). Among states with unsuppressed 2020 data, Louisiana had the highest rate (1.09 per 100,000), while Texas had the largest death count (n=35).
Conclusion
Hypertensive-disease mortality among U.S. adolescents and young adults aged 15-29 years more than doubled from 1999-2020, with HHD representing the dominant subtype. The burden was concentrated among males, Black individuals, persons aged 25-29 years, and the South, supporting earlier blood-pressure detection and cardiometabolic prevention before mid-adulthood.
Zitieren
APA
Patel, K., Hirpara, A. A., Sandhu, D. S., Kaur, M., Solanki, N., Thakkar, H., Gopi, G., AMIN, V., Adrejiya, P., Abubaker, M., & Patel, D. (2026). Abstract TH244: Rising Hypertensive Heart Disease Mortality Among U.S. Adolescents and Young Adults Aged 15-29 Years, 1999-2020. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th244
Vancouver
Patel K, Hirpara AA, Sandhu DS, Kaur M, Solanki N, Thakkar H, et al. Abstract TH244: Rising Hypertensive Heart Disease Mortality Among U.S. Adolescents and Young Adults Aged 15-29 Years, 1999-2020. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th244
BibTeX
@article{Patel2026,
author = {Patel, Khushbu and Hirpara, Akash Arvindbhai and Sandhu, Damanpartap singh and Kaur, Mandeep and Solanki, Nilay and Thakkar, Hemang and Gopi, Gokul and AMIN, VISHRANT and Adrejiya, Parth and Abubaker, Mohammad and Patel, Digantkumar},
title = {Abstract TH244: Rising Hypertensive Heart Disease Mortality Among U.S. Adolescents and Young Adults Aged 15-29 Years, 1999-2020},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th244}
}
EUVIMED